Tatva Chintan Pharma Chem profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 5.5% | 5.5% | 0.8% | 4.9% | 9.2% | ||
| 4.6% | 4.6% | 0.7% | 3.9% | 6.4% | ||
| 7.4% | 7.4% | 0.9% | 6.8% | 10.1% | ||
| 7.0% | 4.6% | 0.6% | 4.2% | 7.8% | ||
Margins | ||||||
| 19.5% | 18.4% | 8.9% | 17.3% | 14.3% | ||
| 11.1% | 11.1% | 1.7% | 10.8% | 12.1% | ||
| — | 40.4% | 334.0% | 28.0% | — | ||
| 13.0% | 11.3% | 2.0% | 11.1% | 10.6% | ||
| 9.7% | 8.3% | 1.5% | 7.7% | 10.7% | ||
| 9.7% | 8.3% | 1.5% | 7.7% | 10.7% | ||
| −16.3% | −16.3% | −13.5% | −7.7% | −41.4% | ||
Additional | ||||||
| 25.4% | 26.2% | 24.6% | 30.3% | −1.6% | ||
| — | 5.6% | 81.9% | 15.4% | 9.7% | ||
| 5.5% | 5.2% | 0.1% | 4.1% | 8.3% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.